infirmary, a digital health company founded in Poland offers Artificial Intelligence-based solutions for symptom analysis and patient classification. Raised $30 million in capital in Serie B. The round was led by One Peak and included participation from previous investors Karma Ventures, the European Bank for Reconstruction and Development, Heal Capital and Inovo Venture Partners.
Founded in 2012, Infermedica aims to make it easier for doctors to pre-diagnose, classify and refer their patients to the appropriate medical services. The company's mission is to make primary care more accessible and affordable by introducing automation to healthcare. infirmary has created a B2B platform for health systems, clients and providers that automates the selection of patients, the admission process and the follow-up after a visit. Since its launch, infirmary It is being used in more than 30 countries in 19 languages and has performed more than 10 million health checks.
The company offers a preliminary diagnostic symptom checker, AI-powered software that helps call operators make timely triage recommendations, and an application programming interface that allows users to build custom diagnostic solutions from scratch. Like a plethora of competitors, such as Ada Health and Babylon, infirmary combines the expertise of clinicians with its own algorithms to offer symptom classification and patient advice.
Infermedica CEO Piotr Orzechowski will use the investment to further develop the company's Physician Guidance Platform and add new modules to cover the full primary care journey. Last year, the team infirmary grew 80% to 180 specialists, including doctors, data scientists and engineers. Orzechowski says that infirmary has an ambitious plan to almost double his team in the next 12 months.
Image: Infermedica
“We will be investing heavily in our people and our products, implementing new modules of our platform and expanding our underlying AI capabilities in terms of disease coverage and accuracy,” Orzechowski said. "From a business perspective, we aim to strengthen our position in the United States, Germany, Austria and Switzerland, and we will concentrate the majority of our sales and marketing efforts there."
Looking ahead, Orzechowski said he strongly believes there will be fully automated self-care bots in 5 to 10 years that will be available 24/7 to help providers find solutions to simple health problems. , such as a cold or urinary infection.
"According to the WHO, by 2030 we could see a shortage of almost 10 million doctors, nurses and midwives worldwide," Orzechowski said. “Having certain limitations on how quickly we can train healthcare professionals, our long-term plan assumes that AI will become a core element of all modern healthcare systems by guiding patients and automating mundane tasks, saving clinical staff valuable time and supporting them with clinically accurate technology.”
The Series B round of infirmary it follows another Series A investment round of 10 million in August 2020. The round was led by the European Bank for Reconstruction and Development (EBRD) and digital health fund Heal Capital. Existing investors Karma Ventures, Inovo Venture Partners and Dreamit Ventures also participated in the round.
